Premium Focus Pays Off For Swisse In China
H&H Group reports sales up 5% at its Adult Nutrition and Care business in the opening nine months of 2025 driven by growing demand for premium Swisse-branded dietary supplements in China.
HBW Insight - December 5, 2025

Praxis Primed For Two US Filings In Early 2026
A submission to the FDA in the coming months for essential tremor drug ulixacaltamide could be swiftly followed by a filing of relutrigine for two rare forms of epilepsy.
Scrip - December 5, 2025

‘Exceptional’ Bimzelx Performance Powers Another Outlook Hike At UCB
Roughly four months after raising its 2025 revenue forecast, UCB has done it again, helped by strong performance of its IL-17A and IL-17F inhibitor.
Scrip - December 5, 2025

Formycon Delivers On Keytruda Biosimilar Partnership Promise With A MS Pharma Deal
While the long-awaited pembrolizumab biosimilar deal certainly boosts Formycon’s financials, it is unclear whether it will be enough to meet its annual guidance.
Generics Bulletin - December 5, 2025

Fresenius Kabi Adopts AI To Optimize Biosimilar And Antibody Manufacturing
Partnership aims to improve yields, cut development time, and bring data-driven control to bioprocessing.
Generics Bulletin - December 5, 2025

NICE Rules-Based Pathway Tops Conference Talking Points For UK Healthtechs
Digital technology and AI have pushed healthcare delivery to a transformational turning point, but market access, budget constraints and scaling adoption of innovation remain the eternal challenges for healthtech manufacturers.
Medtech Insight - December 5, 2025

Asia Deal Watch: Kelun And Crescent Partner And Cross-License Cancer Candidates
Plus deals involving Simcere/Vigonvita, Formosa/Rxilient, Shionogi/Japan Tobacco, Taiho/NEC/JFCR, Toray/Sanodyne, SK Biopharmaceuticals/WARF, BioCorteX/CD Biopharma, ToolGen/GenEditBio and Actimed/Mankind.
Scrip - December 5, 2025

Tracy Beth Høeg Named Acting Director Of US FDA Drug Center
In another surprise leadership move, Commissioner Martin Makary named Høeg, who has stirred controversy with her involvement in FDA vaccine issues, the interim replacement for Richard Pazdur.
HBW Insight - December 5, 2025

Drug Combinations May Be The Next Generation Of Alzheimer’s Treatment
Doctors and biopharma executives discussed the opportunities and challenges for researching and administering combination therapy at the Clinical Trials on Alzheimer’s Disease meeting.
Scrip - December 5, 2025